Wen-Jie Jiao1, Jing Xu, Hao Pan, Tian-You Wang, Yi Shen. 1. Department of Thoracic Surgery, Peking University First Hospital, No. 8, Xishiku Street, Beijing 100034, China. jiaowenjie@163.com
Abstract
AIM: To investigate the effect of endothelin-1 in the invasion of esophageal cancer and determine whether cathepsin B plays a role in the course. METHODS: Western blotting was employed to detect the expression of ET-1 protein in 75 samples of esophageal squamous cell cancer and matched normal esophageal mucosa. Bosentan, a dual ET (A/B)-receptor antagonist, was used to inhibit the binding of endothelin-1 and its receptors and cut down its biological role. In vitro matrigel invasion assays were made to show the invasive ability of esophageal cancer cells with and without bosentan. Subsequently, we evaluated cathepsin B activity and expression in EC9706 cell with and without bosentan. RESULTS: We found 74.7% (56/75) tumors had an overexpression of ET-1 protein by Western blotting. Bosentan significantly inhibited matrigel invasion of cancer cells in vitro. EC9706 cells have a positive expression of cathepsin B protein, and bosentan can down-regulate its expression and activity. CONCLUSION: Endothelin-1 may enhance the invasive ability of human esophageal cancer cells, and its role is correlated with cathepsin B.
AIM: To investigate the effect of endothelin-1 in the invasion of esophageal cancer and determine whether cathepsin B plays a role in the course. METHODS: Western blotting was employed to detect the expression of ET-1 protein in 75 samples of esophageal squamous cell cancer and matched normal esophageal mucosa. Bosentan, a dual ET (A/B)-receptor antagonist, was used to inhibit the binding of endothelin-1 and its receptors and cut down its biological role. In vitro matrigel invasion assays were made to show the invasive ability of esophageal cancer cells with and without bosentan. Subsequently, we evaluated cathepsin B activity and expression in EC9706 cell with and without bosentan. RESULTS: We found 74.7% (56/75) tumors had an overexpression of ET-1 protein by Western blotting. Bosentan significantly inhibited matrigel invasion of cancer cells in vitro. EC9706 cells have a positive expression of cathepsin B protein, and bosentan can down-regulate its expression and activity. CONCLUSION:Endothelin-1 may enhance the invasive ability of humanesophageal cancer cells, and its role is correlated with cathepsin B.
Authors: Giuseppe Portale; Jeffrey A Hagen; Jeffrey H Peters; Linda S Chan; Steven R DeMeester; Tasha A K Gandamihardja; Tom R DeMeester Journal: J Am Coll Surg Date: 2006-04 Impact factor: 6.113
Authors: Z Q Yang; I Imoto; Y Fukuda; A Pimkhaokham; Y Shimada; M Imamura; S Sugano; Y Nakamura; J Inazawa Journal: Cancer Res Date: 2000-09-01 Impact factor: 12.701
Authors: Laura Rosanò; Francesca Spinella; Valeriana Di Castro; Maria Rita Nicotra; Shoukat Dedhar; Antonio Garcia de Herreros; Pier Giorgio Natali; Anna Bagnato Journal: Cancer Res Date: 2005-12-15 Impact factor: 12.701
Authors: T Tanaka; M Sho; T Takayama; K Wakatsuki; S Matsumoto; K Migita; M Ito; K Hamada; Y Nakajima Journal: Br J Cancer Date: 2013-12-19 Impact factor: 7.640
Authors: Iulia Solomon; Vlad Mihai Voiculescu; Constantin Caruntu; Mihai Lupu; Alexandra Popa; Mihaela Adriana Ilie; Radu Albulescu; Ana Caruntu; Cristiana Tanase; Carolina Constantin; Monica Neagu; Daniel Boda Journal: Dis Markers Date: 2018-05-08 Impact factor: 3.434